Author(s): Torres E, Moreno E, Ancizu S, Barea C, Galiano S,
Abstract Share this page
Abstract The increase in the prevalence of drug-resistant tuberculosis cases demonstrates the need of discovering new and promising compounds with antimycobacterial activity. As a continuation of our research and with the aim of identifying new antitubercular drugs candidates, a new series of quinoxaline 1,4-di-N-oxide derivatives containing isoniazid was synthesized and evaluated for in vitro anti-tuberculosis activity against Mycobacterium tuberculosis H37Rv strain. Moreover, various drug-like properties of new compounds were predicted. Taking into account the biological results and the promising drug-likeness profile of these compounds, make them valid leads for further experimental research. Copyright © 2011 Elsevier Ltd. All rights reserved.
This article was published in Bioorg Med Chem Lett
and referenced in Biochemistry & Pharmacology: Open Access